The paper examines 901 global publications in limbic encephalitis as indexed in Scopus database during 2004–13, witnessing an annual average growth rate of 17.27% and an average citation impact per paper of 5.76. The limbic encephalitis publication output came from 48 countries, of which the top 10 (United States, Japan, UK, Germany, France, Spain, Italy, etc.) accounted for 92.45% global publication share during 2004–13. Limbic encephalitis output came from 210 organizations, of which the top 10 contributed 19.98% share during 2003–12. The largest publication share (91.56%) in limbic encephalitis came from medicine, followed by neurosciences (34.52%), biochemistry, genetics and molecular biology (6.77%), psychiatry (4.66% 0 and immunology and microbiology (3.0%) Three countries, namely Spain, Austria and UK out of 10 have achieved higher share of relative index than the average relative citation index of 1.91 of top 10 countries during 2004–13.